Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

KADIAN

BGP PHARMA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of KADIAN in Canada?

A shortage of KADIAN 100MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 22, 2026), but it has not started yet.

Why is KADIAN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will KADIAN be available again?

The manufacturer's estimated resolution date is September 29, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Expected resolution~1 day remaining (estimate)
Affected strength100MG
Last updated2026-09-22

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.

Other Products

ORAMORPH SR TABLETS 100MG

Extended-Release

ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM

100MG · DIN 01988743

Same strengthDifferent dosage formSame routeNo current shortage

STATEX

KNIGHT THERAPEUTICS INC.

5MG · DIN 00594652

Different strengthDifferent dosage formSame routeNo current shortage

MS.IR

PURDUE PHARMA

10MG · DIN 02014211

Different strengthDifferent dosage formSame routeNo current shortage

MS CONTIN

PURDUE PHARMA

60MG · DIN 02014300

Different strengthDifferent dosage formSame routeNo current shortage

M-ESLON

ETHYPHARM INC

30MG · DIN 02019949

Different strengthDifferent dosage formSame routeNo current shortage

M.O.S. SULPHATE 50MG TAB

VALEANT CANADA LP / VALEANT CANADA S.E.C.

50MG · DIN 02009706

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02184451

Strength

100MG

Dosage Form

CAPSULE (EXTENDED-RELEASE) CAPSULE (SUSTAINED-RELEASE)

Route

ORAL

Active Ingredient

MORPHINE SULFATE

See all MORPHINE SULFATE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History